4 recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 4 |
Follow SCC - Squamous Cell Carcinoma: new trials by email Literature Review of SCC - Squamous Cell Carcinoma trials Research Report on SCC - Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma Cetuximab (EGFR inhibitor), 18F-NOTA-ABY-030, Positron Emission Tomography (PET) - SCC - Squamous Cell Carcinoma, Radiotracer | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 25 | 2026-04-24 | 2026-05-11 |
| Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer VRP-encapsulated saRNA encoding IL-12 (1 x 10^9 viral particles per injection), Pembrolizumab (KEYTRUDA®), VRP-encapsulated saRNA encoding IL-12 (3 x 10^8 viral particles per injection) - Head and Neck Cancers- Squamous Cell, Head and Neck Cancer | Phase 1 | Recruiting | VLP Therapeutics | 41 | 2025-05-13 | 2026-09-21 |
| Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer Panitumumab IRDye 800 - HNSCC, HNSCC,Larynx, Pharynx and Oral Cavity | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 70 | 2025-04-17 | 2026-08-03 |
| A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer MQ719, Pembrolizumab - Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 56 | 2023-05-04 | 2026-08-12 |
Carcinoma, Squamous Cell (4) · Squamous Cell Carcinoma of Head and Neck (4) · Head and Neck Neoplasms (2) · Mouth Neoplasms (2) · Neoplasms (2) · Adenocarcinoma, Sebaceous (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Skin Appendage (1) · Hemangiosarcoma (1) · Laryngeal Diseases (1) · Melanoma (1) · Neoplasm Metastasis (1) · Paget Disease, Extramammary (1) · Sarcoma, Kaposi (1)
Carcinoma (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Squamous Cell (4) · Head and Neck Neoplasms (2) · Mouth Diseases (2) · Neoplasms (2) · Stomatognathic Diseases (2) · Adenocarcinoma (1) · Carcinoma, Neuroendocrine (1) · DNA Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Neoplasms, Adnexal and Skin Appendage (1)
pembrolizumab (2) · Cetuximab (1) · Magnetic Resonance Spectroscopy (1)
Vanderbilt-Ingram Cancer Center (2) · Memorial Sloan Kettering Cancer Center (1) · VLP Therapeutics (1)
United States (4)
Eben L Rosenthal, MD (1) · Eben Rosenthal, MD (1) · Fred M Baik, MD (1) · Lara Dunn, MD (1)